Some market commentary from today..
DJ CSL Target Price Cut 3.0% to A$326.00/Share by Goldman Sachs
CSL Price Target Cut 1.9% to A$265.00/Share by Morgan Stanley
Morgan Stanley now estimates that blood plasma collections by biopharma giant CSL will be down 25% in the June and September quarters, a worse decline than the 10% Morgan Stanley was previously predicting. Costs are also expected to rise by 5% per liter. Part of the problem is that Florida, California and Arizona, three states where the coronavirus recently accelerated, account for 30% of CSL's plasma-collection capability. Although collection centers are open, the pandemic and related social-distancing measures are making some donors wary. For Australia-based CSL, which reports fiscal 2020 earnings in August, the slowdown in plasma collections will be reflected in future sales, Morgan Stanley says. The investment bank has an equal-weight rating on CSL shares for now.
Some market commentary from today..DJ CSL Target Price Cut 3.0%...
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$312.73 |
Change
3.545(1.15%) |
Mkt cap ! $150.6B | |||
| Open | High | Low | Value | Volume |
| $311.01 | $313.50 | $310.40 | $66.85M | 214.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 101 | $312.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $312.73 | 111 | 6 |
View Market Depth
| Last trade - 13.06pm 23/07/2024 (20 minute delay) ? |
| CSL (ASX) Chart |